Trending Stories
From the latest healthcare headlines to MedAxiom community news, this is the place to learn more and stay informed. Updated regularly.
Addressing Data and Image Integration as a Strategic Imperative in the CVSL
Partner News | Published: Thursday, July 9, 2020
Learn how ScImage’s PICOM365 provides a turnkey end-to-end solution for data and image integration in this white paper that was developed in partnership with ScImage. Hear from MedAxiom members that have chosen their solution and the benefits they have experienced in workflows and overall work-life balance.
Benefits for the Conversion of OBL to a Hybrid OBL/ASC
Partner News | Published: Thursday, June 4, 2020
By: Robert J. Zasa, CEO, ACA Cardiovascular, LLC and rzasa@acacardiovascular.com Heather Combs, RN , COO, ACA Cardiovascular hcombs@acacardiovascular.com Interventional cardiovascularMedAxiom Announces Industry Partnership With Cell>Point
Partner News | Published: Monday, June 1, 2020
Cell>Point, LLC. is a leader in the development and commercialization of molecular imaging and targeted therapeutics.
The Benefits of a Sale-Leaseback Real Estate Transaction
Partner News | Published: Wednesday, May 20, 2020
Many factors influence your decision to execute a sale-leaseback of your building, including deal terms, asset location, strength of the practice, and tenure of the physicians. In this white paper from Physicians Realty Trust, a trusted industry partner, learn what factors to consider as you determine if the timing is right to look at a potential sale-leaseback for your real estate.
Cardiac imaging company Genetesis adds TDK Ventures as strategic investor
Partner News | Published: Wednesday, May 13, 2020
Genetesis Inc, a MedAxiom partner and medical technology company that has developed non-invasive, biomagnetic CardioFlux™ imaging, has announced several important updates. The company has closedKeeping Your Patient Appointment Schedule Intact During (and After) the COVID-19 Pandemic
Partner News | Published: Monday, May 11, 2020
Medical practices are working through multiple issues brought on by the COVID-19 pandemic: supplying needed care for patients, uncertainties in staffing, PPE supply, PPP funding, and preserving revenue. SomeFarxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction
Partner News | Published: Thursday, May 7, 2020
AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV)A FAST, COMPREHENSIVE APPROACH FOR RE-OPENING YOUR CV SERVICE LINE
Partner News | Published: Monday, May 4, 2020
As we emerge from the unprecedented COVID-19 crisis, programs across the country are seeking a safe, rational approach to re-opening their Cath Labs and resuming elective revascularization. MedAxiom IndustryTDK Ventures Invests in Biomagnetic Medical Imaging Company Genetesis
Partner News | Published: Wednesday, April 29, 2020
TDK Corporation (TSE:6762) announces that subsidiary TDK Ventures Inc. adds to its growing portfolio of companies with an investment in Genetesis, a world leader in non-invasive biomagnetic imaging. GenetesisCARDIAC PET/CT MPI – Preparing your nuclear cardiac imaging lab during uncertain times
Partner News | Published: Wednesday, April 29, 2020
COVID-19, or the Coronavirus, has been the source of widespread concern across the country. This is a severe illness for those with a compromised immune system such as the elderly or those with preexisting